Applied Materials Today, Journal Year: 2024, Volume and Issue: 38, P. 102193 - 102193
Published: April 17, 2024
Language: Английский
Applied Materials Today, Journal Year: 2024, Volume and Issue: 38, P. 102193 - 102193
Published: April 17, 2024
Language: Английский
Theranostics, Journal Year: 2024, Volume and Issue: 14(13), P. 5336 - 5370
Published: Jan. 1, 2024
Ischemic heart disease (IHD) is increasingly recognized as a significant cardiovascular with growing global incidence. Interventions targeting the oxidative microenvironment have long been pivotal in therapeutic strategies. However, many antioxidant drugs face limitations due to pharmacokinetic and delivery challenges, such short half-life, poor stability, low bioavailability, side effects. Fortunately, nanotherapies exhibit considerable potential addressing IHD. Nanomedicines offer advantages passive/active targeting, prolonged circulation time, enhanced diverse carrier options. This comprehensive review explores advancements nanomedicines for mitigating IHD through stress regulation, providing an extensive overview researchers field of nanomedicines. By inspiring further research, this study aims accelerate development novel therapies myocardial injury.
Language: Английский
Citations
2Journal of Drug Delivery Science and Technology, Journal Year: 2024, Volume and Issue: 102, P. 106322 - 106322
Published: Oct. 24, 2024
Language: Английский
Citations
2European Polymer Journal, Journal Year: 2023, Volume and Issue: 197, P. 112365 - 112365
Published: Aug. 12, 2023
Language: Английский
Citations
6Journal of Non-Crystalline Solids, Journal Year: 2024, Volume and Issue: 631, P. 122938 - 122938
Published: March 22, 2024
Language: Английский
Citations
1Applied Materials Today, Journal Year: 2024, Volume and Issue: 38, P. 102193 - 102193
Published: April 17, 2024
Language: Английский
Citations
1